Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer

Breast Journal

Volumn 11, Issue 6, 2005, Pages 448-453

  Kapranos, Nikiforos ^a   Kounelis, Sophia ^b   Karantasis, Helen ^a   Kouri, Efi ^b  

^a Gastroenterology Department   (Greece)

^b HELENA VENIZELOU HOSPITAL   (Greece)

Author keywords

Breast cancer; Chromosomes 1,7; DNA ploidy; Immunochemistry; Interface cytogenetics

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CHROMOSOME 1; CHROMOSOME 7; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOPHOTOMETRY; DNA CONTENT; DNA DETERMINATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MASTECTOMY; PLOIDY; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 28544438282     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.00123.x     Document Type: Article

References (45)

1. Dey P. Aneuploidy and malignancy: an unsolved equation. J Clin Pathol 2004;57:1245-49.
2. Duesberg P, Rausch C, Rasnick D, Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci USA 1998;95:13692-97.
3. Li Y, Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 1996;274:246-48.
4. Hoyt MA. A new view of the spindle checkpoint. J Cell Biol 2001;154:909-12.
5. Cahil D, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998;392:300-303.
6. Pathak S, Multoni AS, Furlong CI, Sohn SH. Telomere dynamics, aneuploidy, stem cells, and cancer [review]. Int J Oncol 2002;20:637-41.
7. Pandis N, Jin Y, Gorunova L, Peterson C, et al. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer 1995;12:173 -85.
8. Steinarsdottir M, Petursdottir I, Snorradottir S, Eyfjord JE, Omundsdottir HM. Cytogenetic study of breast carcinomas: different karyotypic profiles detected by direct harvesting and short-term culture. Genes Chromosomes Cancer 1995;13:239-48.
9. Kontogeorgos G, Kapranos N, Orphanidis G, Rologis D, Kokka E. Molecular cytogenetics of chromosome 11 in pituitary adenomas: a comparison of fluorescence in situ hybridization and DNA ploidy study. Hum Pathol 1999;30:1377-82.
10. Anamthawat-Johnson K, Eyfyord JE, Ogmundsdottir HM, Petursdottir I, Steinarsdottir M. Instability of chromosomes 1,3,16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization. Cancer Genet Cytogenet 1996;88:1-7.
11. Persons DL, Robinson RA, Hsu PH, et al. Chromosome-specific aneusomy in carcinoma of the breast, Clin Cancer Res 1996;2:883-88.
12. Mendelin J, McComma G, Wallis T, Visscher DW. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescent in situ hybridization. Lab Invest 1999;79:387-93.
13. Mialche A, Louis J, Cassaneli S, Seignerin D. Chromosome 11 aneuploidy detected by fluorescent in situ hybridization (FISH) in breast cancer: relation with progesterone receptor expression. Cytopathology 1999;10:79-86.
14. Harrison M, Magee HM, O'Loughlin J, Corey TF, Dervan PA. Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal breast carcinoma in situ of the breast. J Pathol 1995;175:303-9.
15. Yamamoto D, Senzaki H, Nakagawa H, Okugawa H, Gondo H, Tanaka K. Detection of chromosomal aneusomy by fluorescence in situ hybridization for patients with nipple discharge. Cancer 2003;97:690-94.
16. Tsukamoto F, Miyoshi Y, Koyama H, et al. Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine-needle aspirates from breast tumors: application to the preoperative diagnosis of breast. Cancer 2000;90:373-78.
17. Bose S, Mohammed M, Shintaku P, Rao PN. Her-2/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17/Her-2/neu polysomy. Breast J 2001;7:337-44
18. Naquib RN, Sakim HA, Lakshmi MS, et al. DNA ploidy and cell cycle distribution of breast cancer aspirate cells measured by image cytometry and analyzed by artificial neural networks for their prognostic significance. IEEE Trans Inf Technol Biomed 1999;3:61-69.
19. Azua J, Romeo P, Serrano M, Martinez TD, Azua J Jr. Prognostic value for DNA quantitation by static cytometry in breast cancer. Anat Quant Cytol Histol 1997;19:80-86.
20. Heim S, Mitelman F. Nonrandom chromosome abnormalities in cancer - an overview. In: Heim S, Mitelman F, eds. Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, New York: John Wiley & Sons, 1995:19-32.
21. Trent JM. Cytogenetic and molecular biologic alteration in human breast cancer: a review. Breast Cancer Res Treat 1985;5:221-29.
22. Adeyinka A, Mertens F, Idvall I, Bondeson L, Pandis N. Multiple polysomies in breast carcinomas: preferential gain of chromosomes 1,5, 6, 7,12,16,17,18, and 19. Cancer Genet Cytogenet l999;111:144-48.
23. Tsukamoto F, Miyoshi Y, Egawa C, et al. Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization. Cancer 2001;93:165-70.
24. Ichikawa D, Hashimoto N, Hoshima M, et al. Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer 1996;77:2064-69.
25. Hirata K, Tagawa Y, Kashima K, et al. Frequency of chromosome 7 gain in human breast cancer cells: correlation with the number of metastatic lymph nodes and prognosis. Tohoku J Exp Med 1998;184:85-97.
26. Farabegoli F, Ceccarelli C, Santini D,et al. Chromosome 1 aneusomy with 1p36 under-representation is related to histologie grade, DNA aneuploidy, high c-erbB-2 and loss of bcl-2 expression in ductal breast carcinoma. Int J Cancer 1996;69:381-85.
27. McManus DT, Patterson AH, Maxwell P, et al. Interphase cytogenetics of chromosomes 11 and 17 in fine needle aspirates of breast cancer. Hum Pathol 1999;30:137-44.
28. Farabegoli F, Baldini N, Santini D, et al. Relation between deletion of chromosome Ip36 and DNA ploidy in breast carcinoma: an interphase cytogenetic study. J Clin Pathol Mol Pathol 1996;49:M98-103.
29. Bofin AM, Ytterhus B, Fjosne HE, Hagmar BM. Abnormal chromosome 8 copy number in cytological smears from breast carcinomas detected by means of fluorescence in situ hybridization (FISH). Cytopathology 2003;14:5-11.
30. Simpson JF, Quan DE, Ho JP, Slovak ML. Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization. Am J Pathol 1996;149:751-58.
31. Hedley DW, Rugg CA, Gelber RD. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 1987;47:4729-35.
32. Vindelov LL, Christensen IJ, Jensen G, Nissen NI. Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry 1983;3:332-39.
33. Persons DL, Takai K, Gibney DJ, Katzman JA, Lieber MM, Jenkins RB. Comparison of fluorescence in situ hybridization with flow cytometry and static image analysis in ploidy analysis of paraffinembedded prostate adenocarcinoma. Hum Pathol 1994;25:678-83.
34. Carey FA. Measurement of nuclear DNA content in histological and cytological specimens: principles and applications. J Pathol 1994;172:307-12.
35. Cajulis RS, Kotliar S, Haines GK, Frias-Hidvegi D, O'Gorman M. Comparative study of interphase cytogenetics, flow cytometric analysis, and nuclear grade of fine-needle aspirates of breast carcinoma. Diagn Cytopathol 1994;11:151-58.
36. Mark HF. Interphase cytogenetics for studying solid tumors. Cancer 1998;83:839-43.
37. Mark HF, Huth A, Santora K, Ferreira K, Barker B. Sequential flow cytometry and fluorescence in situ hybridization for the study of formalin-fixed, paraffin-embedded breast cancer tissues. Cancer Genet Cytogenet 1997;98:1-5.
38. Hedley DW, Clark GM, Cornelisse CJ, et al. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference. Cytometry 1993;14:482-85.
39. Toikkanen S, Joensuu H, Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer - a study with longterm follow-up. Br J Cancer 1989;60:693-700.
40. Camplejohn RS, Ash CM, Gillett CE, et al. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre. Br J Cancer 1995;71:140-45.
41. O'Reilly SM, Camplejohn RS, Barnes DM, et al. DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 1990;61:671-74.
42. Stanton PD, Cooke TG, Oakes SJ, et al. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. Br J Cancer 1992;66:925-29.
43. Harrison MM, Magee HM, O'Loughlin JF, et al. Comparison of chromosome 1 aneusomy detected by interphase cytogenetics and DNA ploidy in carcinoma of the breast. Histopathology 1997;30:221-26.
44. Shackney SE, Singh SG, Yakulis R, et al. Aneuploidy in breast cancer: a fluorescence in situ hybridization study. Cytometry 1995;22:282-91.
45. Herrington CS, Leek RD, McGee JO. Correlation of numerical chromosome 11 and 17 imbalance with metastasis of primary breast cancer to lymph nodes. J Pathol 1995;176:353-59.